InvestorsHub Logo

edcpf

02/20/16 12:16 PM

#253825 RE: Protector #253823

If we go by the book, I don't think it's forbidden to have a pharma employee editing pharma-related articles. As for his restriction, I do not currently understand what his fault exactly was for being blocked?

Our case has always been quite weak for having most of the MOS numbers for bavituximab on Wikipedia, specifically those numbers which have only been released by Peregrine itself in a PR or a presentation by people affiliated with Peregrine, and not through 3rd party sources such as another encyclopedia.

Also, the IR department of Peregrine cannot do anything about Wikipedia, and it would be a major incident if they were in any way involved in editing it.

tech0200

02/21/16 11:31 PM

#253944 RE: Protector #253823

There can be no question that it was done deliberately. Whoever is behind this like the CA suit, the trial sabotage doesn't want PPHM to succeed. What I think is troubling is that someone is still out there attacking PPHM. We might feel that it is no possible to have another trial sabotage when the Sunrise trial is being done at so many different sites. What if they compromise the results of just one patient? How would that play out? It might not make a difference in the overall results but I think it can still do a lot of damage to the credibility of the entire trial. What safeguards are there this time that were not there during the phase II trial? The fact that you have so many sites now gives the enemy more targets.